可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Brownlee M.Biochemistry and molecular cell biology of diabetic complications[J].Nature,2001,414(6865):813-820.
[2]Hamilton SJ,Chew GT,Watts GF.Therapeutic regulation of endothelial. dysfunction in type 2 diabetes mellitus[J].Invited review,2007,4(2):89-102.
[3]Jiang JL,Zhang XH,Li NS,et al.Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity[J].Cardiovasc Drugs Ther,2006,20(4):281-294.
[4]Kirkby NS,Hadoke PW,Bagnall AJ,et al.The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?[J].Br J Pharmacol,2008,153(6):1105-1119.
[5]成永霞,刘贵波,郭素芬,等.AGEs诱发体外大鼠心脏微血管内皮细胞iNOS表达[J].基础医学与临床,2010,30(5):515-519.
[6]Guzik TJ,Mussa S,Gastaldi D,et al.Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitrieoxide synthase[J].Circulation,2002,105(14):1658-1662.